The Pentagon will pay Philips millions for technology of instant identification COVID-19 at military

At the end of December, 2020 Philips and BioIntelliSense companies benefited a grant in the amount of nearly $2.8 million from the U.S. Department of Defense for development of technology of instant identification of COVID-19 at military. According to Philips, the company should accelerate a research and the subsequent implementation of the wearable diagnostic BioSticker device for the benefit of military and public health care.

In cooperation with the Medical campus of Anschutz of the Colorado Royal Philips University is going to conduct clinical trial with participation of 2500 participants who contacted to sick COVID-19 recently and/or test early symptoms of COVID-19.

The Pentagon will pay Philips millions for technology of instant identification COVID-19 at military - BioSticker

BioSticker provides continuous multiple parameter monitoring of key indicators of life activity and the symptoms including connected with COVID-19. A system is integrated into offers of Philips on remote monitoring of patients to provide collecting and data analysis in a cloud. The founder and the CEO of BioIntelliSense doctor James Mault noted that he in combination with the advanced diagnostic algorithms BioSticker can form a basis for identification of cases of COVID-19 on very early terms. It not only will help to begin earlier treatment, but also will reduce spread of a virus among the population.

Our purpose - to benefit by wearable technologies and to check prediction algorithms which will help us to identify the people infected with COVID-19, before emergence of the expressed symptoms, - the director of a study program of military operational medicine Christopher Steel noted. - Results of this research directly will affect combat readiness of army and can bring benefit to the population in general as these tools will be used out of medical institutions.[1]

Notes